|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
31.650 -1.300 (-3.945%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 345,182 | -66.521% | 1,031,041 | 4,299,702 | 18,544 | 0 |
| Cost of Sales | (1,221,201) | 0.292% | (1,217,648) | (1,297,769) | (13,804) | -- |
| Gross Profit | (876,019) | 369.446% | (186,607) | 3,001,933 | 4,740 | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (15,046) | 71.425% | (8,777) | (1,824) | (391) | (241) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,217 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (1,978,884) | 67.135% | (1,184,001) | 1,936,787 | (396,638) | (156,766) | |
| Taxation | 11,451 | -94.777% | 219,244 | (29,701) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 484,701 | 776.082% | 55,326 | 7,304 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,482,732) | 63.040% | (909,431) | 1,914,390 | (396,638) | (156,766) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (56,298) | -69.526% | (184,741) | (25,175) | (4,221) | (43,479) |
| Depreciation & Amortisation | 271,476 | 18.053% | 229,962 | 99,417 | 31,741 | 22,473 |
| Directors' Emoluments | 21,816 | -16.250% | 26,049 | 22,831 | 27,008 | 7,850 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -601.000 | 63.315% | -368.000 | 774.000 | -172.000 | -77.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 80.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 10.336% | -- | -- |
| Cash flow per share ($) | (3.713) | -- | (7.641) | 8.141 | (2.033) | (0.837) |
| NBV per share ($) | 21.316 | -- | 27.271 | 32.310 | 24.534 | 6.605 |
| Remarks: | Real time quote last updated: 13/11/2024 16:43 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -225,373,000 |
| %Change | -73.215% |
| EPS / (LPS) | RMB -0.910 |
| NBV Per Share (¥) | RMB 20.447 |